Kilbee will be responsible for driving the portfolio globally including increased emphasis on digital and content
Chris Kilbee appointed Group Director of UBM Pharma Portfolio
Kilbee will be responsible for driving the portfolio globally including increased emphasis on digital and content
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
